🔥 Thursday 10 July 2025 Thu, 10 July 2025

Vulcan Energy Resources has raised €30 million through a strategic placement led by BNP Paribas’ Clean Energy Solutions Fund to advance critical development stages of its Phase One Lionheart lithium project.

Vigorous Resources has launched an unconditional off-market takeover bid for all shares of Rey Resources Limited at a 155-160% premium, with unanimous board support and major shareholder backing. The offer period runs from 9 July to 11 August 2025.

Rey Resources Limited has dispatched its Target's Statement recommending shareholders accept an unconditional $0.028 per share cash offer from Vigorous Resources Pty Ltd. The bid, which offers a significant premium over historical prices, opens on 9 July and closes on 11 August 2025.

Robex Resources reports strong grade control drilling results from the Mansounia deposit, reinforcing confidence in the Kiniero Gold Project's planned Q4 2025 production. The company also secures US$25 million in funding to advance construction.

Echo IQ has secured a pivotal reseller agreement with US-based SARC MedIQ, unlocking access to over 300 healthcare facilities and accelerating adoption of its AI-driven EchoSolv AS technology across the American cardiology landscape.

First Au Limited has launched its inaugural diamond drilling program at the Nimba Gold Project in Liberia, securing ownership of a drilling rig to bolster its West African exploration ambitions.

GTi Energy has raised $2.5 million from the first tranche of a $4.5 million placement to fund drilling at its Lo Herma uranium project, with key permits expected in August and a strategic investment from Snow Lake Energy pending shareholder approval.

Manuka Resources has boosted the net present value of its Cobar Basin silver and gold project to A$153 million, driven by higher commodity prices, while advancing financing talks and exploring a Mt Boppy open pit cut-back to enhance production.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Imagion Biosystems has received encouraging feedback from the FDA on its planned Phase 2 HER2 breast cancer clinical trial, paving the way for its Investigational New Drug application submission later this year.

Ausgold Limited has raised A$35 million through a well-supported placement to accelerate its Katanning Gold Project in Western Australia towards a final investment decision.

Chariot Corporation Ltd is set to acquire a 66.7% interest in a substantial Nigerian lithium portfolio, marking a strategic entry into Africa’s burgeoning lithium sector with a US$10 million funding commitment.

Turaco Gold’s latest drilling near the Woulo Woulo deposit reveals exceptional high-grade gold intercepts and expands mineralised zones at the Afema Project in Côte d’Ivoire.

G50 Corp has confirmed a significant new precious metals discovery at its Golconda Project in Arizona, revealing extensive gold, silver, and zinc mineralization from its latest drilling program. The results also highlight notable gallium mineralization, underscoring the project's strategic value.

Victory Metals has significantly enhanced its North Stanmore resource with Gallium inclusion and secured major financing commitments exceeding US$200 million, positioning itself as a strategic supplier amid global rare earths tensions.

Neurizon Therapeutics has received positive feedback from the FDA on its plan to resolve the clinical hold on its ALS drug candidate NUZ-001, with key preclinical studies completed ahead of schedule. The company aims to resume clinical trials in late 2025.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Australian Rare Earths Limited (ASX, AR3) has acquired exploration license EL6895, adding 972 km² to its Overland Uranium Project and uncovering significant near-surface uranium potential from historic data. Drilling is set to resume in July 2025 to test this promising new target alongside existing deeper uranium prospects.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project by 160%, with promising assay results and a planned drilling program to confirm mineral continuity. The company is positioning itself to benefit from strong EU demand for rare earths, titanium, and silicon metals.

Pacgold has identified a compelling IP chargeability anomaly coincident with a magnetic bullseye at its White Lion Prospect, echoing signatures seen at the Mt Leyshon gold deposit. Drilling is planned for Q4 2025 following heritage clearances.

American West Metals reports promising visual copper mineralisation from deep drilling and identifies multiple new targets via advanced geophysics at its Storm Copper Project in Nunavut, Canada.

Kinterra Infrastructure has increased its takeover offer for New World Resources shares to A$0.063, with a potential rise to A$0.064 if it secures over 30% ownership. This move intensifies the takeover battle against rival CAML, promising quicker payments and stronger funding assurances.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.

Change Financial has surpassed its FY25 revenue targets and is set to report its first positive underlying EBITDA, signaling a pivotal shift for the fintech. The company also projects strong revenue and earnings growth for FY26, underpinned by robust sales momentum and operational efficiencies.